Oral Melanoacanthoma

Updated: Jun 26, 2018
  • Author: Talib Najjar, DMD, MDS, PhD; Chief Editor: Jeff Burgess, DDS, MSD  more...
  • Print


Melanoacanthoma is a rare condition of oral mucosa that has been reported only in the last century. The lesion is characterized by a proliferation of both melanocytes and keratinocytes that results in pigmented macular or plaquelike lesions (see image below).

Intraoral melanoacanthoma lesion on the mandibular Intraoral melanoacanthoma lesion on the mandibular gingiva.

Oral melanoacanthoma is regarded by many as a reactive condition unrelated to cutaneous melanoacanthoma, but the histologic features are similar. Cutaneous and mucosal melanoacanthoma differ in terms of patient age, patient race, and site.

In 1927, Bloch provided the earliest known description of melanoacanthoma, which was reported in the German literature. [1] Bloch described several skin lesions, which he originally called benign nonovoid melanoepithelioma of the skin. He further subdivided his cases into 2 types: In the histologic samples studied, type 1 had both dendritic melanocytes and keratinocytes, whereas the histologic appearance of type 2 was similar to that of type 1, but it lacked the dendritic melanocytes.

In 1960, Mishima and Pinkus reexamined the condition and further refined the diagnostic terminology. [2] The condition that Bloch designated as type 1 is currently called melanoacanthoma, and type 2 is currently called pigmented seborrheic keratosis. [3]

Although cutaneous lesions of melanoacanthoma were reported as early as 1927, Tomich et al at the American Academy of Oral Pathology first reported oral mucosal lesions in 1978. [1] Although many authors subsequently published case reports, Goode et al published the first case report in 1983. [4] This was a retrospective review of 10 cases of oral melanoacanthoma reported in the literature.

To date, oral melanoacanthoma remains a rare condition, with approximately fewer than 100 reported cases. The cutaneous variant is also rare; however, it is more prevalent than the mucosal variant.



The mucosal variants of melanoacanthoma have histologic appearances similar to that of cutaneous melanoacanthoma. The lesion consists of proliferating melanocytes and keratinocytes, which result in large pigment-containing dendritic cells. The dendritic cells are present throughout the middle and upper layers of the epithelium. See the image below.

Diagram of a pigmented epithelial macule. Diagram of a pigmented epithelial macule.

Inflammation occurs almost universally in patients with mucosal lesions. The presence of inflammation and the spontaneous resolution of oral lesions are suggestive of a reactive process rather than a neoplastic process. [5] The observation of trauma and inflammation associated with oral lesions has led to the conclusion that the mucosal variant is likely the result of a reactive process rather than a neoplastic process. [6]



The role of trauma in the development of the lesion remains controversial, but any irritant must be removed. BRAF inhibitor therapy may play a role in some cases. [7]



US frequency

Oral melanoacanthoma is rare, with only approximately fewer than 100 cases reported since 1978, [8, 9, 10] when the lesions were first reported. The cutaneous variant is more common, but it is still relatively rare among skin lesions. Among all the cases reported, specific patterns are described with respect to the race, sex, and age of patients with cutaneous melanoacanthomas and those with mucosal melanoacanthomas.


Cutaneous lesions of melanoacanthoma are reported almost exclusively in white patients. The mucosal variant is reported almost exclusively in black patients. [11, 12] Some sporadic mucosal cases are reported in Asian individuals.


The prevalence for both variants of melanoacanthoma is fairly equal in both sexes, with a slight female predominance. [13] The female-to-male ratio is approximately 3:2.


The age distributions of the 2 types of melanoacanthoma differ. [14] Cutaneous lesions are found in patients with a mean age of approximately 60 years. Mucosal lesions appear in patients with a mean age of approximately 25 years.



Initially, cutaneous lesions were suspected to be malignant, and subsequently, the lesions were linked to a transformation to low-grade malignancy. Malignant transformation has been reported in at least 2 cases. However, most lesions are considered benign and should be treated conservatively.

No cases of recurrence or metastasis have been reported in either the mucosal variant or cutaneous variant. A low risk of recurrence exists. To date no malignant oral melanoacanthoma have been reported.